Shareholders Meetings

Share capital and voting rights*

Share capital: €5,034 582.90
Number of shares outstanding: 100,691,658
Total number of voting rights: 106,134,467

*As of May 31, 2026

All 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Jun 2017
11:20 E.S.T.

Shareholders’ General Meeting – June 26, 2017 – Report on the regulated agreements

Download the PDF file

Jun 2017
10:07 E.S.T.

Shareholders’ General Meeting – June 26, 2017 – Report on the consolidated financial statements

Download the PDF file

Jun 2017
09:45 E.S.T.

Shareholders’ General Meeting – June 26, 2017 – Report on the financial statements

Download the PDF file

May 2017
20:50 E.S.T.

Notice of combined shareholders’ meeting of June 26, 2017

Download the PDF file

Get updates

Get the latest on gene-editing innovation, financial and business news from Cellectis with our email alert service.